Publicacións en colaboración con investigadores/as de Universitat Autònoma de Barcelona (28)

2023

  1. Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders

    Brain Sciences, Vol. 13, Núm. 2

2021

  1. Blood biomarker panels for the early prediction of stroke-associated complications

    Journal of the American Heart Association, Vol. 10, Núm. 5, pp. 1-8

  2. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  3. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

2020

  1. Blood biomarkers predictive of epilepsy after an acute stroke event

    Epilepsia, Vol. 61, Núm. 10, pp. 2244-2253

  2. Correlation of blood biomarkers with early-onset seizures after an acute stroke event

    Epilepsy and Behavior, Vol. 104

  3. Corrigendum to “Correlation of blood biomarkers with early-onset seizures after an acute stroke event” [Epilepsy Behav 104(Pt B) (2020 Mar)] (Epilepsy & Behavior (2020) 104(PB), (S1525505019305219), (10.1016/j.yebeh.2019.106549))

    Epilepsy and Behavior

2019

  1. PATJ Low Frequency Variants Are Associated with Worse Ischemic Stroke Functional Outcome: A Genome-Wide Meta-Analysis

    Circulation Research, Vol. 124, Núm. 1, pp. 114-120

2017

  1. GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke

    Stroke, Vol. 48, Núm. 5, pp. 1147-1153

2014

  1. Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: A systematic review and meta-analysis

    Journal of Neuroimmunology, Vol. 274, Núm. 1-2, pp. 215-224

  2. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): A randomised, double-blind phase 2b/3 trial

    The Lancet Neurology, Vol. 13, Núm. 5, pp. 453-460

2013

  1. Hemorrhagic risk of emergent endovascular treatment plus stenting in patients with acute ischemic stroke

    Journal of Stroke and Cerebrovascular Diseases, Vol. 22, Núm. 8, pp. 1326-1331

2012

  1. A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke

    Annals of Neurology, Vol. 72, Núm. 5, pp. 716-729

  2. Reliability of the ABC/2 Method in Determining Acute Infarct Volume

    Journal of Neuroimaging, Vol. 22, Núm. 2, pp. 155-159

  3. Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients

    Stroke, Vol. 43, Núm. 5, pp. 1398-1400

2011

  1. A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke

    Stroke, Vol. 42, Núm. 1, pp. 196-203

  2. Acute damage to the posterior limb of the internal capsule on diffusion tensor tractography as an early imaging predictor of motor outcome after stroke

    American Journal of Neuroradiology, Vol. 32, Núm. 5, pp. 857-863

  3. The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome

    Thrombosis and Haemostasis, Vol. 105, Núm. 3, pp. 421-429

2010

  1. Association of growth factors with arterial recanalization and clinical outcome in patients with ischemic stroke treated with tPA

    Journal of Thrombosis and Haemostasis, Vol. 8, Núm. 7, pp. 1567-1574

  2. Mechanical thrombectomy with the solitaire AB device in large artery occlusions of the anterior circulation: A pilot study

    Stroke, Vol. 41, Núm. 8, pp. 1836-1840